当前位置:首页 - 行情中心 - 诚达药业(301201) - 财务分析 - 现金流量表

诚达药业

(301201)

  

流通市值:38.45亿  总市值:54.80亿
流通股本:1.09亿   总股本:1.55亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金107,366,146.78470,723,644.57337,456,785.95209,499,121.98
  收到的税费返还279,315.46-2,710,909.412,388,382.86
  收到其他与经营活动有关的现金8,846,033.7359,781,641.419,971,655.78,579,640.39
  经营活动现金流入小计116,491,495.97530,505,285.97360,139,351.06220,467,145.23
  购买商品、接受劳务支付的现金80,205,663.54284,784,688.72178,074,991.1124,165,522.08
  支付给职工以及为职工支付的现金26,681,027.3894,357,271.1971,171,518.6747,336,951.39
  支付的各项税费6,595,363.664,651,007.335,985,608.265,440,443.48
  支付其他与经营活动有关的现金14,421,949.53112,694,571.3138,445,335.1120,133,318.02
  经营活动现金流出小计127,904,004.11496,487,538.55293,677,453.14197,076,234.97
  经营活动产生的现金流量净额-11,412,508.1434,017,747.4266,461,897.9223,390,910.26
二、投资活动产生的现金流量:
  收回投资收到的现金884,000,0008,245,048,197.055,829,968,276.273,460,022,696.25
  取得投资收益收到的现金1,799,459.1918,147,672.5317,353,463.569,904,454.46
  处置固定资产、无形资产和其他长期资产收回的现金净额135,3281,222,770.64256,717231,725
  投资活动现金流入小计885,934,787.198,264,418,640.225,847,578,456.833,470,158,875.71
  购建固定资产、无形资产和其他长期资产支付的现金24,048,516.7769,019,320.84110,558,933.0174,434,947.59
  投资支付的现金844,000,0007,929,000,002.235,124,000,0002,785,000,000
  投资活动现金流出小计868,048,516.777,998,019,323.075,234,558,933.012,859,434,947.59
  投资活动产生的现金流量净额17,886,270.42266,399,317.15613,019,523.82610,723,928.12
三、筹资活动产生的现金流量:
  取得借款收到的现金-8,951,765.598,079,3008,079,300
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-8,951,765.598,079,3008,079,300
  偿还债务支付的现金4,95030,000,00030,000,000-
  分配股利、利润或偿付利息支付的现金399,125.3732,821,485.2830,921,641.611,237,233.96
  筹资活动现金流出小计404,075.3762,821,485.2860,921,641.611,237,233.96
  筹资活动产生的现金流量净额-404,075.37-53,869,719.69-52,842,341.616,842,066.04
四、汇率变动对现金及现金等价物的影响-773,506.1776,311.8641,316.71683,532.64
五、现金及现金等价物净增加额5,296,180.81247,323,656.68627,280,396.84641,640,437.06
  加:期初现金及现金等价物余额424,264,827.58176,941,170.9176,941,170.9176,941,170.9
  期末现金及现金等价物余额429,561,008.39424,264,827.58804,221,567.74818,581,607.96
补充资料:
  净利润--11,961,222.21-12,995,531.41
  资产减值准备-35,566,178.42-4,184,500.97
  固定资产和投资性房地产折旧-71,130,418.9-34,430,870.83
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,130,418.9-34,430,870.83
  无形资产摊销-1,832,260.09-770,048.1
  长期待摊费用摊销-18,059,299.8-8,624,562.17
  处置固定资产、无形资产和其他长期资产的损失--37,332.75--37,332.75
  固定资产报废损失-5,746,454.83-445,480.02
  公允价值变动损失--2,849,373.74--2,964,478.63
  财务费用-1,505,103.08--755,430.47
  投资损失--12,343,763.11--6,273,243.09
  递延所得税--4,694,010.2--992,744.01
  其中:递延所得税资产减少--4,162,210.96--489,061.73
    递延所得税负债增加--531,799.24--503,682.28
  存货的减少--39,582,455.85--20,844,628.7
  经营性应收项目的减少--22,505,527.48--22,511,366.5
  经营性应付项目的增加--5,848,282.36-10,548,886.24
  其他---5,770,254.67
  现金的期末余额-424,264,827.58-818,581,607.96
  减:现金的期初余额-176,941,170.9-176,941,170.9
  现金及现金等价物的净增加额-247,323,656.68-641,640,437.06
公告日期2026-04-282026-04-282025-10-282025-08-26
审计意见(境内)标准无保留意见
TOP↑